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Edited by Stuart FergusonAbstract Those aerobic archaea whose genomes have been
sequenced possess a single 4-gene operon that, by sequence
comparisons with Bacteria and Eukarya, appears to encode the
three component enzymes of a 2-oxoacid dehydrogenase multi-
enzyme complex. However, no catalytic activity of any such
complex has ever been detected in the Archaea. In the current
paper, we have cloned and expressed the ﬁrst two genes of this
operon from the thermophilic archaeon, Thermoplasma acido-
philum. We demonstrate that the protein products form an a2b2
hetero-tetramer possessing the decarboxylase catalytic activity
characteristic of the ﬁrst component enzyme of a branched-chain
2-oxoacid dehydrogenase multienzyme complex. This represents
the ﬁrst report of the catalytic function of these putative archaeal
multienzyme complexes.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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In aerobic bacteria and eukaryotes, a family of 2-oxoacid
dehydrogenase multienzyme complexes (OADHCs) functions
in the pathways of central metabolism. The complexes are
responsible for the oxidative decarboxylation of 2-oxoacids to
their corresponding acyl-CoAs (Fig. 1). Members of the family
include the pyruvate dehydrogenase complex (PDHC), which
catalyses the conversion of pyruvate to acetyl-CoA and so
links glycolysis and the citric acid cycle; the 2-oxoglutarate
dehydrogenase complex (OGDHC), which catalyses the con-
version of 2-oxoglutarate to succinyl-CoA within the citric acid
cycle; and the branched-chain 2-oxoacid dehydrogenase com-
plex (BCOADHC), which oxidatively decarboxylates the* Corresponding author. Fax: +44-1225-386779.
E-mail address: M.J.Danson@bath.ac.uk (M.J. Danson).
Abbreviations: BCOADHC, branched-chain 2-oxoacid dehydrogenase
complex; DCPIP, 2,6-dichlorophenolindophenol; E1, 2-oxoacid de-
carboxylase; E2, dihydrolipoyl acyl-transferase; E3, dihydrolipoamide
dehydrogenase; FOR, ferredoxin oxidoreductases; Mr, relative molec-
ular mass; OADHC, 2-oxoacid dehydrogenase complexes; OGDHC,
2-oxoglutarate dehydrogenase complex; PDHC, pyruvate dehydroge-
nase complex; TPP, thiamine pyrophosphate
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doi:10.1016/j.febslet.2004.10.058branched-chain 2-oxoacids produced by the transamination of
valine, leucine and isoleucine.
The complexes comprise multiple copies of three component
enzymes: 2-oxoacid decarboxylase (E1), dihydrolipoyl acyl-
transferase (E2) and dihydrolipoamide dehydrogenase (E3) [1–
3]. E2 forms the structural core of the complex, with multiple
polypeptide chains associating into octahedral (24-mer) or
icosahedral (60-mer) conﬁgurations, depending on the partic-
ular complex and the source organism [2,4]. E1 and E3 bind
non-covalently to the E2 core. E1 may occur as a homodimer
or as an a2b2 hetero-tetramer, depending upon the source and
the type of complex, although in all cases E3 is a dimer of
identical subunits.
E2 also forms the catalytic core of the complex (Fig. 1): a lipoyl
moiety, covalently attached to a lysine residue in the lipoyl do-
main, serves as a swinging arm, connecting the active sites of
each enzyme and channelling substrate through the complex [3].
Thus, E1 catalyses the thiamine pyrophosphate (TPP)-depend-
ent oxidative decarboxylation of the 2-oxoacid and the transfer
of the resulting acyl group to the lipoic acid of E2. E2 then
transfers the acyl-group to coenzyme-A, after whichE3 serves to
reoxidise the dihydrolipoylmoiety. It does so by the reduction of
the non-covalently bound co-factor FAD, in conjunction with a
protein disulﬁde bond and an amino acid base, which are
themselves then reoxidised by NADþ, forming NADH.
NoOADHCactivity has ever beendetected in theArchaea [5];
instead, the oxidation of 2-oxoacids is catalysed by an unrelated
and structurally more simple family of 2-oxoacid ferredoxin
oxidoreductases (FORs). This comprises the pyruvate FOR, the
2-oxoglutarate FOR and the 2-oxoisovalerate FOR, which
catabolise pyruvate, 2-oxoglutarate and the branched-chain 2-
oxoacids, respectively [6–8]. The pyruvate FOR from Halobac-
terium halobiumhas ana2b2 structure [9], but in the thermophilic
archaea these enzymes generally contain four diﬀerent subunits
and occur as octamers (a2b2c2d2) [8]. Importantly in the current
context, the FOR’s catalytic reaction does not involve a lipoic
acid moiety or NADþ; rather, the acyl-moiety formed on de-
carboxylation of the 2-oxoacid is handed on direct to coenzyme-
A, and the reducing equivalents to ferredoxin via the enzyme’s
iron-sulfur centre [6].
However, there is growing evidence to suggest that some
archaea may possess an OADHC (reviewed in [10]). Whilst no
whole complex activity has been found, E3 activity and lipoic
acid have been detected in halophilic archaea [11,12] and an
operon containing four genes, whose predicted proteination of European Biochemical Societies.
R COOH
O
R
OH
TPP
H
S
SH
R
O
SH
SH
S
S
R SCoA
O
FAD
-S-S-
B
FAD
HB
TPPH
CO2
E1
E2
E3
CoASH
+
-SH -S-
NAD+ NADH + H+
Lip
Overall reaction:  2-oxoacid + CoA + NAD+ acyl-CoA + CO2 + NADH + H+
Fig. 1. The general reaction catabolised by OADHCs. The complex mechanism is described in Section 1. E1 (2-oxoacid decarboxylase); E2 (di-
hydrolipoyl acyl-transferase); E3 (dihydrolipoamide dehydrogenase). Symbols: B (a histidine base on E3); Lip (enzyme-bound lipoic acid); CoASH
(coenzyme-A); TPP-H (thiamine pyrophosphate); FAD (ﬂavin adenine dinucleotide); NAD (nicotinamide adenine dinucleotide).
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E1a, E1b, E2 and E3 of bacteria and eukaryotes, was subse-
quently found in Haloferax volcanii [13]. E3 activity has also
been detected in cell extracts of Thermoplasma acidophilum
[14]. The recent sequencing of a number of archaeal genomes
has revealed the presence of putative OADHC-encoding op-
erons in the aerobic archaea: H. halobium, T. acidophilum,
Aeropyrum pernix, Pyrobaculum aerophilum, and Sulfolobus
solfataricus. To date, there is no experimental evidence to
suggest that a functional complex is assembled from these
operons, and E3-knockout studies in Hfx. volcanii failed to
elucidate any metabolic function [15].
In the current paper, to elucidate the function of this pu-
tative OADHC in the Archaea, we have cloned and expressed
in Escherichia coli the E1a and E1b genes from the archaeon,E1 E1
  Number of amino acids        338           320  
 Inter-gene distances (bp)  - 3
cgaaaatttttcaccatcgcgttagcaattgtcatgctct
Direction of transcription
Fig. 2. The arrangement, inter-gene distances (base pairs, bp) and proposed
stituting the proposed T. acidophilum OADHC operon. The corresponding
sequence at the 50 end of the E1a gene, plus the upstream region, is shown to i
Dalgarno sequence (doubly underlined) and the ATG start codon. The 30 TGA
are also shown.T. acidophilum, which is a thermoacidophile that grows opt-
imally at 59 C and pH 2.0 [16]. Enzyme assays of the pu-
riﬁed recombinant E1 enzyme show it to be an active
branched-chain 2-oxoacid decarboxylase component, sug-
gesting that the operon in this archaeon encodes a functional
BCOADHC.2. Materials and methods
2.1. Bioinformatics
The putative OADHC operon was identiﬁed in the T. acidophilum
DSM1728 genome from the ENTREZ Nucleotides database (http://
www3.ncbi.nlm.nih.gov). The features of this operon and the ar-
rangement of the four genes [E1a: Ta1438; E1b: Ta1437; E2: Ta1436;
and E3: Ta1435] are illustrated diagrammatically in Fig. 2.E2 E3
               401                         437
+ 5    + 2
gcatggtttcatgagggtgtttg tATGac
tttTGAaccatctcattttattccattttt
direction of transcription (!) of the four open reading frames con-
number of amino acids of the protein products is given. The DNA
llustrate a potential promoter sequence (underlined), a potential Shine–
stop codon and the proposed transcriptional stop signals (underlined)
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T. acidophilum DSM 1728 was grown at 59 C in DSM medium 158
and, after cell lysis in 50 mM Tris buﬀer (pH 7.5), genomic DNA was
extracted according to [17]. The genes encoding E1a and E1b were
individually PCR-ampliﬁed from this T. acidophilum genomic DNA,
using primers that introduced restriction sites to the 50 and 30 ends of
the gene products (XhoI and BamHI for E1a, NheI and BamHI for
E1b). These primers also permitted the introduction of an N-terminal
His tag into the protein products when expressed in the pET vector
system (Novagen). PCR-ampliﬁcation was carried out using Vent po-
lymerase (New England Biolabs), followed by A-tailing with Taq po-
lymerase (Promega). Ampliﬁed DNA fragments were puriﬁed by
electrophoresis in a 0.8% (w/v) agarose gel and extracted using the
Qiaex II Gel Extraction kit (Qiagen). Fragments were separately li-
gated into the pGEM-T (Promega) intermediate cloning vector, from
which the E1a gene fragment was excised and cloned into pET-19b
(Ampr), and the E1b fragment into pET-28a (Kanr), using T4 DNA
ligase, generating the recombinant expression vectors pET-19b-E1a
and pET-28a-E1b.2.3. Expression of gene products
E. coli BL21(DE3)pLysS cells were separately heat-shock trans-
formed with the pET-19b-E1a and pET-28a-E1b constructs. For co-
transformation with both plasmids, cells were ﬁrst transformed with
plasmid pET-19b-E1a and selected by growth on LB agar containing
carbenicillin (50 lg/ml); transformants were then made competent by
treatment with calcium chloride and subjected to a second transfor-
mation, resulting in pET-19b-E1a-pET-28a-E1b co-transformants,
selected for by growth on media containing both carbenicillin (50 lg/
ml) and kanamycin (30 lg/ml).
Single-plasmid transformants were grown in LB media containing
chloramphenicol (34 lg/ml) and either carbenicillin (50 lg/ml) or
kanamycin (30 lg/ml). Following induction with 1 mM isopropyl-b-D-
thiogalactose at OD600 nm 0.6, cells were grown for a further 4 h at 37
C with shaking. Co-transformants were grown in media containing all
three antibiotics and the proteins expressed similarly.2.4. Puriﬁcation of recombinant protein
Co-expressed recombinant E1 proteins were puriﬁed by His-Bind
Resin (Novagen) chromatography and dialysed into 20 mM Tris
buﬀer (pH 9.3), containing 10% (v/v) glycerol. After 24 h, precipi-
tated protein was isolated by centrifugation (16 000 g for 5 min),
resuspended in the same dialysis buﬀer and heated for 20 min at 55
C. After this treatment, remaining insoluble precipitate was removed
by a similar centrifugation and discarded. Purity of E1 in the retained
soluble fraction was examined by SDS–PAGE on a 10% (w/v)
polyacrylamide gel.2.5. Gel ﬁltration
The size of the recombinant E1ab protein was estimated by ana-
lytical gel ﬁltration on an Amersham Biosciences €Akta FPLC system,
using a Superdex 200 10/300GL column equilibrated with 20 mM
sodium phosphate (pH 7.0), 2 mM MgCl2 and 100 mM NaCl. Protein
standards were: b-amylase (Mr¼ 200 000), alcohol dehydrogenase
(150 000), bovine serum albumin (66 000), carbonic anhydrase (29 000)
and cytochrome C (12 400).Fig. 3. SDS–PAGE of puriﬁed T. acidophilum recombinant E1. Lane 1,
standard protein markers (Mr values given in kDa); lane 2, soluble cell
extract; lane 3, enzyme after His-Bind Resin chromatography (E1a and
E1b polypeptides are indicated).2.6. Densitometry
The E1a and E1b protein bands on SDS–PAGE gel were analysed
densitometrically. The Coomassie blue stained gel was scanned using a
Fujiﬁlm FLA-5000 phosphorimager at 473 nm, with an LPG ﬁlter (for
general-purpose excitation ﬂuorescent digitising), and the scanned
image was then analysed using the AIDA 2D Densitometry pro-
gramme (Raytest, Straubenhardt, Germany).
2.7. Enzyme assay
E1 enzymic activity was assayed spectrophotometrically by fol-
lowing the 2-oxoacid dependent reduction of 2,6-dichlorophenolin-
dophenol (DCPIP) at 595 nm [18]. Assays were carried out at 55 C
in 20 mM potassium phosphate (pH 7.0), 2 mM MgCl2 and 0.2 mM
TPP. Buﬀer and recombinant E1a enzyme were pre-incubated at 55
C for 10 min; 50 lM DCPIP was then added and the assay started
by the addition of the 2-oxoacid substrate [either pyruvate, 2-oxo-glutarate, 4-methyl-2-oxopentanoate, 3-methyl-2-oxopentanoate or 3-
methyl-2-oxobutanoate (Sigma–Aldrich)]. Kinetic parameters were
determined by the direct linear method of Eisenthal and Cornish-
Bowden [19].3. Results
3.1. E1 expression and puriﬁcation
All expression experiments used the E. coli BL21(DE3)-
pLysS cell line and were performed at 37 C. Two diﬀerent
methods were used in the attempt to obtain assembled E1
protein. The ﬁrst was the individual expression of E1a and
E1b, to be followed by in vitro mixing of the puriﬁed subunits,
whereas the second method involved co-expression, which
oﬀered the potential of in vivo assembly of the subunits in the
same cellular compartment. In the latter, cells were co-trans-
formed with the recombinant pET-19b-E1a and pET-28a-E1b
plasmids, resulting in E. coli pET-19b-E1a/pET-28a-E1b
co-transformants.
High levels of soluble E1a were obtained by individual ex-
pression of this subunit, although E1b expression was not
detectable under the same conditions (results not shown). As
co-expression experiments were successful in yielding soluble
E1a and E1b subunits, further manipulations to the individual
expression of E1b were not attempted.
Following dialysis of the His-puriﬁed E1ab co-expressed
protein into 20 mM Tris buﬀer (pH 9.3) containing 10% (v/v)
glycerol to remove the imidazole, the majority of protein
precipitated. Resuspension of precipitated protein at 55 C in
the dialysis buﬀer resulted in a highly puriﬁed E1 sample with
an approximately equal ratio of a to b polypeptides. The Mr
values of the a and b polypeptides were determined by SDS–
PAGE to be 43 000 and 37 000, respectively (Fig. 3), which
compares favourably with predicted values of 41 000 and
37 000 from the published gene sequences. Analytical gel ﬁl-
tration revealed a single peak of aroundMr¼ 165 000 that was
enzymically active in the E1 assay. SDS–PAGE of the peak
fraction after gel ﬁltration and subsequent densitometric
analysis showed a 1:1 stoichiometry of the a and b polypep-
tides. Taken together, these data suggest an a2b2 structure for
the active E1 enzyme.
Table 1
Kinetic parameters determined for puriﬁed recombinant E1 from T. acidophilum at 55 C with branched-chain 2-oxoacids, pyruvate and 2-oxo-
glutarate as potential substrates
2-Oxoacid substrate Vmax (U mg1 protein) Kcat (s1) Km (mM) kcat=Km (mM1 s1)
3-Methyl-2-oxopentanoate 0.38 0.50 0.1 5
4-Methyl-2-oxopentanoate 0.13 0.17 0.042 4
3-Methyl-2-oxobutanoate 0.23 0.30 0.027 11
Pyruvate 0.07 0.09 0.6 0.15
2-Oxoglutarate 0 0 0 0
1 Unit of enzyme activity (U) is deﬁned as 1 lmol DCPIP reduced per min.
Values of kcat are calculated per ab dimer of the a2b2 active enzyme.
526 C. Heath et al. / FEBS Letters 577 (2004) 523–5273.2. E1 activity
The recombinant E1 enzyme was incubated with TPP for 10
min prior to assay, a lag in the production of product being
observed if the assay was initiated without prior incubation.
However, increasing the pre-incubation period to 4 h resulted
in no increased E1 activity over that obtained with the 10 min
incubation. E1 enzymic activity was detected with the 2-oxo-
acids 3-methyl-2-oxopentanoate, 4-methyl-2-oxopentanoate,
3-methyl-2-oxobutanoate and pyruvate, but not with 2-oxo-
glutarate. The calculated kinetic parameters with these sub-
strates are given in Table 1.4. Discussion
The discovery in the aerobic archaea of an operon that
would appear to encode the components of a OADHC was
unexpected because the catalytic activity of such multienzyme
systems has never been detected in any archaeon [10]. Also, the
presence throughout the Archaea of catalytically active 2-
oxoacid FORs that catalyse the same chemical conversions as
the OADHCs would argue against a need for the latter
multienzyme systems in these organisms.
However, the detection of enzyme activity for the E3 com-
ponent, dihydrolipoamide dehydrogenase, in cell extracts of
the extreme halophiles [11] and in T. acidophilum [14], suggests
that at least this gene within the operon is functional. Fur-
thermore, sequence analyses and secondary-structural predic-
tions of the putative E1 and E2 enzymes (see [10,13] for
programmes used) support the possibility that these are also
functional proteins. Hawkins et al. [20] describe a common
sequence motif found on the E1a of TPP-binding enzymes,
and propose that this element is associated with TPP binding.
The sequence is generally around 30 amino acids in length,
with highly conserved GDG and NN residues at the N- and C-
termini, respectively. Internally, there is an E or D residue that
is usually conserved, and A and P residues that are generally
conserved. A cluster of hydrophobic residues immediately
precedes the NN [20]. As shown in Fig. 4, the motif has been
located in the E1a of T. acidophilum. In all the bacterial and
eukaryotic OADHCs, the E2 polypeptide chain has three dif-Fig. 4. Alignment of a partial amino acid sequence of T. acidophilum E1a wi
Bacillus stearothermophilus. Highly conserved regions associated with a putati
indicated in bold type. Hydrophobic amino acid clusters are underlined. Id
amino acid position in the E1a polypeptide.ferent domains: one to three copies of an N-terminal lipoyl
domain, an E1–E3 subunit-binding domain, and a catalytic
domain. Structural predictions of the proposed protein prod-
uct of the E2 gene in Hfx. volcanii and T. acidophilum show
that this characteristic domain structure and catalytically im-
portant residues, including the lysine to which the lipoic acid is
covalently bound, are conserved [10].
Given the above experimental results, and since genome
analyses argue strongly against the presence of non-functional
ORFs in prokaryotes [21], the work reported in this paper set
out to discover the possible catalytic function of the putative
OADHCs in Archaea. As the substrate speciﬁcity of OADHCs
is determined by the E1 component, we chose to express the
two genes that, by sequence comparisons, were predicted to
code for the a and b polypeptides of the E1 decarboxylase
component of the complex from the thermophilic archaeon, T.
acidophilum. Co-expression of the putative E1a and E1b genes
in E. coli was necessary to obtain the b protein in soluble form,
suggesting that the a and b components associated with each
other. This association was supported by gel ﬁltration and
SDS–PAGE, an a2b2 enzyme being produced.
The recombinant E1 enzyme was found to possess catalytic
activity with the branched-chain 2-oxoacids derived from the
transamination of the amino acids, valine, leucine and isoleu-
cine. It also exhibited activity with pyruvate as substrate, but
the catalytic eﬃciency, deﬁned as kcat=Km, was 25–70 times
lower than with the branched-chain 2-oxoacids. No activity
could be found with 2-oxoglutarate. Thus, the enzyme may be
the ﬁrst component of a BCOADHC, involved in the catab-
olism of valine, leucine and isoleucine, the acyl-CoA products
then being fed into the citric acid cycle. The E1a2b2 structure
and the catalytic properties are similar to those observed in the
bacterium Bacillus subtilis, where it is proposed that a single
multienzyme complex performs an economic ‘dual role’ of
catalysing the oxidative decarboxylation of both branched-
chain 2-oxoacids and pyruvate [22]. However, in that case, the
activity detected with pyruvate was approximately 50 times
greater than with the branched-chain 2-oxoacids.
Finally, it should be noted that the catalytic activity of the
recombinant T. acidophilum E1 [kcat¼ 0.17–0.50 s1; Table 1]
is similar to that reported for the recombinant E1a2b2th the putative TPP-binding motif of the E1a protein of the PDHC of
ve TPP-binding motif in TPP-binding enzymes, as described in [20], are
entities are indicated by an asterisk. Bracketed numbers give the ﬁrst
C. Heath et al. / FEBS Letters 577 (2004) 523–527 527[kcat ¼ 0:47 s1] from the Bacillus stearothermophilus PDHC,
using the same DCPIP assay but with pyruvate as substrate
[18].
In conclusion, our data suggest that T. acidophilum possesses
a functional E1 that accepts branched-chain 2-oxoacids as
substrate. This is the ﬁrst such activity to be reported in the
Archaea and, with E3 activity already detected in cell extracts
of this organism, is highly suggestive of a functional
BCOADHC in this evolutionary domain of organisms. Thus,
it is reasonable to propose that a OADHC was present in the
common ancestor to the Bacteria and the Archaea, and that it
has been retained in aerobic members of each domain. The 2-
oxoacid FORs are also ancient enzymes but, whereas they are
found in the anaerobic bacteria, they are functional in both
aerobic and anaerobic archaea [7,8]. Furthermore, in the
bacterial domain, the ancestral OADHC appears to have di-
versiﬁed to give several complexes of diﬀerent substrate spe-
ciﬁcities (PDHC, OGDHC and the BCOADHC). We can ﬁnd
only a single complete OADHC operon in each aerobic arch-
aeon, although a second but partial operon has been discov-
ered in Hfx. volcanii [23]. This second operon encodes E1a and
E1b proteins, and an unattached lipoyl domain; whilst no
enzyme activity could be assigned to these products, mutation-
complementation experiments suggest that they are functional
during nitrate-respirative growth on Casamino acids.
It remains to be established whether the complexes from the
various archaea all have the same substrate speciﬁcity, if that
particular activity is always duplicated by the corresponding
FOR in each organism, and how the respective activities are
coordinately regulated. Structurally, the biophysical nature of
the archaeal multienzyme complex is a key question, and rec-
ombinant E2 and E3 components of T. acidophilum must be
now generated, and the ambitious goal of complex assembly
achieved. The identiﬁcation of the catalytic activity of the E1
component in this current paper is an important step to ena-
bling these questions to be investigated.
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